Chrysos (ASX:C79) Research & Development: A$0.00 Mil (TTM As of Dec. 2025)


ASX:C79 Chrysos Corp Ltd ASX:C79
57 GF Score
Price A$5.67
GF Value A$11.92
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Chrysos Research & Development?

Chrysos ASX:C79 -3.08% 57 Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:C79 with a GF Score™ of 57/100 and a GF Value™ of A$11.92 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Chrysos's Research & Development for the six months ended in Dec. 2025 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

Chrysos  (ASX:C79) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Chrysos Research & Development Related Terms

Chrysos Research & Development Historical Data

* Premium members only.

The historical data trend for Chrysos's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chrysos Research & Development Chart

Chrysos Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Research & Development
0.00 0.00 0.00 0.00

Chrysos Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:C79
57GF Score
Chrysos Corp Ltd ASX:C79
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chrysos Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.00 Mil mean?
Chrysos (ASX:C79) has a Research & Development of A$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Chrysos and its competitors.
Is Chrysos' Research & Development too high?
Chrysos' current Research & Development is A$0.00 Mil. Overall, Chrysos has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chrysos' Research & Development compare to CRM and SHOP?
Chrysos' Research & Development of A$0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Chrysos and its competitors. Chrysos's current Research & Development is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chrysos stock overvalued right now?
Based on GuruFocus' analysis, Chrysos (ASX:C79) is currently considered Possible Value Trap. The stock's GF Value™ is A$11.92, compared to a current price of A$5.67 — trading 52.4% below its estimated fair value. The current Research & Development is A$0.00 Mil. Chrysos' overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Chrysos (ASX:C79), the current Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chrysos (ASX:C79) Overvalued in 2026?

Based on GuruFocus' analysis, Chrysos stock appears to be undervalued. The current stock price of A$5.67 is trading 52.4% below its estimated GF Value™ of A$11.92. GuruFocus considers Chrysos to be Possible Value Trap.

Key valuation signals for ASX:C79:

  • Research & Development: A$0.00 Mil
  • GF Value™: A$11.92 vs. price of A$5.67 (52.4% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the ASX:C79 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chrysos Business Description

Other Exchanges CHRCF:USAYI1:Germany
Address 2A Venture Road, Tonsley, SA, AUS, 5042
Chrysos Corp Ltd is an Australian-based provider of novel assay services to the international mining industry through its proprietary PhotonAssay technology. The company's flagship product, PhotonAssay, delivers accurate and environmentally friendly analysis of gold, silver, and complementary elements. The Group has three reportable segments, namely, EMEA, APAC, and the Americas, where the majority of revenue is generated from Australia. The Group generates revenue mainly from the deployment of PhotonAssay units with its customers.
57GF Score

Get the complete analysis for ASX:C79

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.67
Price
A$11.92
GF Value